Economy & Aftermath

3-star hotel will be established in Amri…
With the aim of ensuring various tourist services with suitable prices in coastal area, Ministry of Tourism gave license for establishing a 3-star hotel that includes res...
New York, (ST) - Deputy Foreign and Expatriates...
Minsk, (ST) - The Ambassador of Syria to the...
HASAKA, (ST)_The Turkish occupation forces and...
Palestinian Presidency today condemned the...
WASHINGTON, (ST)_US political commentator James...
DER EZZOUR, HASAKA, (ST)_The US-backed "Syrian...
Majd Al Din Dibo Majd Al Din Dibo was born...
DAMASCUS, (ST- Syria strongly condemns the US...
The Israeli occupation authorities on Wednesday...
Czech writer Daniel Vesely has stressed that...
US President-elect Joe Biden's nominee for...
Havana, (ST) - Cuban President Miguel...
Occupied Al -Quds, (ST) - Israeli occupation...
Geneva,(ST)-Today, the World Health...
The Israeli Occupation forces arrested today...
New York,(ST)-Dr. Bashar al-Jaafari, Deputy...
Amigurumi is the Japanese art of knitting or...
Tehran ,(ST)-Iranian President Hassan Rouhani...
At least two children were martyred on Tuesday...
HASAKA, (ST), The bodies of 7 people, most of...
With the aim of ensuring various tourist services with suitable prices in coastal area, Ministry of Tourism gave license for establishing a 3-star hotel that includes res...
The Arab Cultural center in Abou Rummaneh is currently hosting a sculpture exhibition entitled “Wood and Light Dialogue” for artist Shafiq Al Ghabra . This exhibition sh...
Tartous, (ST)-The quiet village of Bnamra is embraced by mountains of ancient oak trees, in the midst of a charming nature as freshwater springs burst from its tops which makes the village look like an emerald. According to the village mayor, Muhammad Ahmad Shaheen, Bnamra is within the municipality of Sheikh Badr in Tartous. It spreads over an area of about two thousand dunums. The village was named so due to its...
Read moreWith the participation of more than 252 cartoonists from 52 countries around the world, the Arab Writers Union held its first international cartoons exhibition in a new way which dealt with the role of international figures who influenced the literary and cultural movement. The visions of the participating cartoonists' paintings differed in the technique of drawing, but what they all had in common was that they they revealed the impact ...
Read moreIn implementation of the Ministry of Education's plan to support the quality of the educational process, Lattakia Education Directorate is conducting a training course targeting / 120 / trainees in two phases: the first starts on 16/01/2021 until 21/01/2021, and the second for a period of three weeks, starts from 1/29/2021, with the aim of enabling teachers and teaching assistants to apply effective learning strategies, and to intensify content a...
Read moreSyria has renewed its call on the Security Council to act immediately as to enforce the implementation of the Resolution No. 497 of 1981 and force the Israeli occupation entity to stop its illegal settlement activities and repressive procedures against the people in the occupied Syrian Golan and to withdraw from the entire Golan to the June 4th 1967 line. Resolution 497 (1981) reaffirms that the acquisition of ter...
Read moreTaking aspirin every day may significantly reduce the risk of many cancers and prevent tumors from spreading, according to two new studies published on Tuesday.
Drawbacks of daily doses of aspirin include a risk of gastrointestinal bleeding.
The findings add to a body of evidence suggesting that cheap and widely available aspirin may be a powerful if overlooked weapon in the battle against cancer. But the research also poses difficult questions for doctors and public health officials, as regular doses of aspirin can cause gastrointestinal bleeding and other side effects. Past studies have suggested that the drawbacks of daily use may outweigh the benefits, particularly in healthy patients.
One of the new studies examined patient data from dozens of large, long-term randomized controlled trials involving tens of thousands of men and women. Researchers at the University of Oxford found that after three years of daily aspirin use, the risk of developing cancer was reduced by almost 25 percent when compared with a control group not taking aspirin. After five years, the risk of dying of cancer was reduced by 37 percent among those taking aspirin.
A second paper that analyzed five large randomized controlled studies in Britain found that over six and a half years on average, daily aspirin use reduced the risk of metastatic cancer by 36 percent and the risk of adenocarcinomas — common solid cancers including colon, lung and prostate cancer — by 46 percent.
Daily aspirin use also reduced the risk of progressing to metastatic disease, particularly in patients with colorectal cancer, the studies reported.
The studies, led by Dr. Peter M. Rothwell, a professor of clinical neurology at the University of Oxford, were published in the medical journal The Lancet. A third paper by Dr. Rothwell and his colleagues, published in The Lancet Oncology, compared the findings of observational studies and randomized trials of aspirin.
There is an urgent need for clinical trials of treatment regimens incorporating aspirin, Dr. Rothwell said.
“What really jumps out at you in terms of prevention is the striking 75 percent reduction in esophageal cancer and a 40 to 50 percent reduction in colorectal cancer, which is the most common cancer right now,” Dr. Rothwell said. “In terms of prevention, anyone with a family history would be sensible to take aspirin,” he added.
But while some experts called the new findings “provocative” and “encouraging,” mounting evidence about the preventive promise of aspirin puts health providers in a quandary. Aspirin increases the risk of not just of gastrointestinal bleeding, but of hemorrhagic strokes.
The new studies, however, also found that the risk of bleeding in aspirin users diminished over time, and that the risk of death from brain bleeds was actually lower in the aspirin users than in the comparison group.
“I think he’s on to something. I just want to be cautious, and I don’t want to exaggerate,” said Dr. Otis W. Brawley, chief medical officer and executive vice president of the American Cancer Society. “I’m not ready to say that everybody ought to take a baby aspirin a day to prevent cancer.”
Dr. Andrew T. Chan, an associate professor of medicine at Harvard Medical School and co-author of a comment published with the articles in The Lancet, said the studies, despite their limitations, “raise the level of excitement about using aspirin as a chemopreventive agent.”
“If you start to include the possibility that aspirin reduces the cancer risk beyond colon cancer, then the risk-benefit ratio shifts quite a bit, especially for those cancers where we have little to offer in the way of screening and early diagnosis,” Dr. Chan said.
The randomized clinical trials the Oxford investigators examined were not focused on cancer prevention; they were originally intended to study the effects of aspirin on preventing heart disease. The application of the findings to cancer prevention may be flawed, some experts said.
In the United States, two major studies of low-dose aspirin to prevent cancer did not find reductions in cancer with aspirin use. Those findings were excluded from analysis by the Oxford researchers because they involved use of aspirin every other day, rather than daily use.
Though many people use baby aspirin daily to reduce their risk of heart disease, patients are generally advised to do so only when their cardiac risk is presumed to outweigh the risks of taking aspirin. Physicians remain extremely reluctant to recommend long-term use of aspirin in a healthy population.
Some cancer doctors commended the new research, saying that despite the limitations of the analyses, no other long-term clinical trials of aspirin and cancer are likely to be done because of the enormous expense involved and the fact that aspirin is a cheap generic drug.
Source:The Newyork Times
B.N